Synergistic effects of Bifidobacterium thermophilum RBL67 and selected prebiotics on inhibition of Salmonella colonization in the swine proximal colon PolyFermS model by Sabine Amani Tanner et al.
Tanner et al. Gut Pathogens 2014, 6:44
http://www.gutpathogens.com/content/6/1/44RESEARCH Open AccessSynergistic effects of Bifidobacterium thermophilum
RBL67 and selected prebiotics on inhibition of
Salmonella colonization in the swine proximal
colon PolyFermS model
Sabine Amani Tanner, Christophe Chassard, Annina Zihler Berner and Christophe Lacroix*Abstract
Background: Probiotics and prebiotics are promising strategies to counteract Salmonella prevalence in swine. In
the present study, we investigated the effects of prebiotics (fructo- (FOS), galacto- (GOS) and mannan- (MOS)
oligosaccharides) and the bacteriocinogenic Bifidobacterium thermophilum RBL67 (RBL67) on Salmonella enterica
subsp. enterica serovar Typhimurium N-15 (N-15) colonization using the PolyFermS in vitro continuous fermentation
model simulating the swine proximal colon.
Material and methods: The PolyFermS model was designed with a first-stage reactor containing immobilized fecal
pig microbiota. This reactor continuously inoculated five parallel second-stage reactors, a control and four treatment
reactors, all operated with proximal colon conditions. FOS and GOS (5.2 g/day), and MOS (half dosage) and RBL67
(108 copy numbers/mL applied daily) were tested on the ability of N-15 to colonize reactors, inoculated with the
same microbiota. Reactor effluents were collected daily and analyzed for microbial composition (quantitative PCR
and 454 pyrosequencing of 16S rRNA gene pool) and main metabolites (HPLC).
Results: RBL67 and N-15 were shown to stably colonize the system. Colonization of N-15 was strongly inhibited
by FOS and GOS, whereas addition of RBL67 alone or combined with MOS showed intermediate results. However,
the effect of FOS and GOS was enhanced when prebiotics were combined with a daily addition of RBL67. FOS
and GOS increased the total short chain fatty acid production, especially acetate and propionate. RBL67 combined
with FOS additionally stimulated butyrate production.
Conclusions: Our study demonstrates the suitability of the porcine PolyFermS in vitro model to study nutritional
effects of pro- and prebiotics on gut microbiota composition and activity. It can further be used to monitor
Salmonella colonization. The inhibition effects of FOS and GOS on N-15 colonization are partly due to an increased acetate
production, while further antimicrobial mechanisms may contribute to an enhanced inhibition with prebiotic-RBL67
combinations. A future direction of this work could be to understand the anti-Salmonella effects of Bifidobacterium
thermophilum RBL67 in the presence of prebiotics to unravel the mechanism of this probiotic:pathogen interaction.
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Salmonella are highly prevalent in swine where they affect
about one third of all production holdings in the European
Union [1]. Salmonella negatively impact pig health and
the productivity of livestock. Transmission to humans
occurs via the food-chain, leading to severe infections.
Therefore, Salmonella control must be initiated at the
farm level. Since antibiotics for growth promotion have
been banned, alternative strategies to improve gut health
are necessary to maintain productivity. Gut microbial com-
position and activity can be directly influenced via the diet
[2]. This in turn impacts the colonization ability of enteric
pathogens, such as Salmonella, through competitive exclu-
sion mechanisms [3]. Probiotics and prebiotics, known
for their potential to modulate gut microbial compos-
ition and activity, are amongst the promising alterna-
tive strategies [4].
Probiotics are defined as “live microorganisms which,
when administered in adequate amounts, confer a health
benefit on the host” [5]. Beneficial effects attributed to
probiotics in pig feed include reduced incidence and se-
verity of infections and decreased shedding of pathogens
[6-8]. For example, weaned pigs treated with a five strain
probiotic mixture (four Lactobacillus strains and one
Pediococcus strain) showed significantly reduced (>2 log10
cfu/g feces) Salmonella numbers at 15 days post-infection
[7]. Other authors report a lower incidence of diarrhea
and fecal coliform numbers when feeding Lactobacillus
rhamnosus GG [9], reduced carriage of Escherichia coli
with Bifidobacterium lactis HN019 [10], or decreased
Salmonella counts in feces and tissues after feeding pigs a
combination of Lactobacillus acidophilus and Lactobacillus
reuteri [8].
Prebiotics are non-digestible food-ingredients that are
readily fermentable in the colon and stimulate potentially
health-promoting bacteria, mainly bifidobacteria and/or
lactobacilli, thereby beneficially shifting the microbial equi-
librium of the host gut [11]. For example, Patterson et al.
[12] reported stimulation of Bifidobacterium spp. and
Lactobacillus spp. with a concomitant suppression of
Clostridium spp. and members of Enterobacteriaceae spp.
upon feeding of inulin to pigs. Prebiotics can stimulate
short chain fatty acid (SCFA) production, known to play a
key role in intestinal host health. For example, butyrate, the
main energy source for colonocytes, has anti-inflammatory
and anti-carcinogenic properties (reviewed by Russell et al.
[13]) and down-regulates the expression of genes associated
with Salmonella invasion [14]. However, conflicting results
have been reported for the effects of prebiotic feeding in
pigs. Tzortzis et al. [15] reported higher acetate concen-
trations and increased bifidobacteria numbers after feeding
GOS to pigs, while Mikkelsen and Jensen [16] showed
increased butyrate production after feeding FOS to pig-
lets. In contrast, no effect was observed with FOS onbifidobacterial populations [17] and on fecal SCFA con-
centrations [18]. Prebiotics are increasingly combined
with probiotics (synbiotics) to enhance probiotic sur-
vival and growth. Synbiotic formulations tested in pigs
decreased the level of Enterobacteriaceae in pig fecal
samples [19], and reduced adherence of Escherichia coli
O8:K88 to the jejunal and colonic mucosa [20]. However,
synbiotic formulations have been much less studied for
pathogen inhibition. Yet, they have a promising potential
considering the competitive advantage of the probiotic
through simultaneous application of a prebiotic with high
specificity [21,22].
The species B. thermophilum belongs to the commensals
of the pig gut microbiota [23]. Bifidobacterium thermophilum
RBL67 (RBL67) previously isolated from baby feces was
shown to produce a bacteriocin-like substance (BLIS) with
in vitro activity against Listeria and Salmonella [24-26].
Furthermore, we recently showed that RBL67 has antag-
onistic effects on Salmonella infection in an in vitro con-
tinuous intestinal fermentation model simulating the child
proximal colon [27]. This strain was reported to adhere to
human intestinal cell lines [28] and to exert protective ef-
fects on epithelial HT29-MTX cell culture integrity upon
Salmonella challenge in combined cellular and colonic
fermentation models [29]. Inulin supplemented in a three-
stage continuous intestinal fermentation model of the child
induced an increase of B. thermophilum numbers in the
proximal, transverse and distal colon sections while SCFA
production was shifted towards higher butyrate concentra-
tions [30]. However, inulin in the proximal colon environ-
ment of the model was also shown to promote Salmonella
growth [30], and to increase the efficiency of HT29-MTX
cell invasion [29]. Finally, RBL67 has technological fea-
tures of interest for application, such as being moderately
oxygen-tolerant, growing at high cell density, low pH and
high temperatures of up to 47°C [31].
Studying the complex interplay of pro- and prebiotics
with the gut microbiota and pathogens is hindered by the
inaccessibility of the gastrointestinal tract. Studies are fur-
ther challenged by ethical limits to conduct in vivo animal
infection trials. In this context, in vitro models represent
a cost-effective and ethically less constraint strategy [32].
We recently reported and validated a novel two-stage
in vitro continuous fermentation model (PolyFermS) inocu-
lated with immobilized fecal microbiota simulating the
swine proximal colon. This model allows the parallel oper-
ation of five self-contained independent fermentations to
simultaneously test different nutritional factors with the
same microbiota [33]. In this study, we used this PolyFermS
model of the swine proximal colon to investigate the effects
of B. thermophilum RBL67 and prebiotics (FOS, GOS and
MOS) on the gut microbiota composition and activity and
on the colonization of the enteric pathogen Salmonella
enterica subsp. enterica serovar Typhimurium N-15 (N-15).
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Colonization potential of RBL67 and N-15
To evaluate the colonization ability of RBL67 and N-15 in
an in vitro model of the swine proximal colon, we inocu-
lated TRs once with RBL67 with and without FOS or with
N-15 during period 1 (Figure 1). RBL67 and N-15 concen-
trations were estimated 96 h after addition and data were
compared to the theoretical washout curve (Figure 2).
The N-15 cell counts initially declined at a rate close to
the theoretical washout curve and stabilized after 27 h at
4.7 ± 0.2 log10 cfu/mL until 96 h. RBL67 gene copy num-
bers (CN) (8.1 log10 CN/mL) declined faster than the
theoretical washout curve during the first 54 h and reached
a stable value of 4.6 ± 0.2 log10 CN/mL between 78 and
96 h. A similar pattern was observed for the treatment of
RBL67 combined with FOS, with CN decreasing until 27 h,
followed by stability (5.3 ± 0.3 log10 CN/mL, 27–96 h).
Effect of prebiotics and RBL67 on N-15 colonization
Pretreatments with RBL67 and prebiotics were tested dur-
ing periods 2–4 on N-15. After N-15 infection in period 2,
N-15 cell counts declined 1.6 log10 cfu/mL during the first
2 days and stabilized at 5.0 ± 0.2 log10 cfu/mL effluent (days
2–5) (Figure 3). Unexpectedly, N-15 cell counts in the fol-
lowing periods showed either a limited initial decline phase
after the first day of challenge followed by stability (6.3 ±Figure 1 Experimental set-up of the continuous fermentation exper
F: flow rate; M: fresh medium inflow; stab: stabilization; prev: prevention; challen
thermophilum RBL67; R-FOS/GOS/MOS: B. thermophilum RBL67 + respective pre0.1 log10 cfu/mL, period 3, days 1–5), or a steady increase
until day 2 to reach 7.4 ± 0.1 log10 cfu/mL (period 4, days
2–5). The treatments with FOS and GOS during periods 2
and 3 induced a strong inhibition of N-15 colonization,
with N-15 cell numbers decreasing below the detection
limit (4.1 log10 cfu/mL effluent) 3 days post-infection.
When FOS or GOS were combined with RBL67 (R-FOS
and R-GOS) during periods 2–4, N-15 counts decreased
even more rapidly compared to treatments with the prebi-
otics alone, reaching non-detectable levels after two days
post-infection (periods 2 and 3) or reducing initial N-15
counts by approximately 2 log10 cfu/mL (period 4). Inter-
mediate effects were recorded for RBL67 alone (periods 2
and 3) and in combination with MOS (R-MOS, period 4),
with a reduction of N-15 counts 2 days post-infection by
approximately 1.8 ± 0.3 and 0.7 log10 cfu/mL, respectively.
Effect of prebiotics, RBL67 and N-15 infection on gut
microbiota composition
Changes in the microbial community composition were
monitored by qPCR and by 454 pyrosequencing. We com-
pared mean copy numbers (days 2–4) of bacterial popula-
tions during pseudo-steady states of N-15 challenge periods
of control and treatment reactors.
Bacteroides-Prevotella and Clostridium Cluster IV were
the most prominent groups, followed by Enterobacteriaceae,iment. IR: inoculum reactor; CR: control reactor; TR: test reactors 1–4;
ge: challenge with Salmonella N-15; N-15: S. Typhimurium N-15; RBL67: B.
biotic.
Figure 2 Salmonella and B. thermophilum in reactor effluents compared to theoretical washout curves during colonization tests. RBL67
was added once to TR2 and TR4 to reach 108 CN/mL, while TR4 was additionally supplied with 5.2 g of FOS/day. N-15 was added once to TR1 to
reach 106 cfu/mL. Salmonella viable cell counts in reactor effluents was measured by plating on CHROMAgar™. B. thermophilum numbers were
estimated by qPCR. Measured concentrations were compared to a theoretical washout curve.
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(Table 1). Total 16S rRNA, Clostridium Cluster IV and
Bacteroides-Prevotella gene copy numbers remained stable
independent of the tested conditions. Furthermore, the
other bacterial groups, except for Bifidobacterium, did
not show large changes (difference to CR <0.5 log10 CN/
mL) upon treatment application. Bifidobacterium numbers
increased by more than 1 log10 CN/mL during treatments
with RBL67 alone and RBL67 combined with prebiotics
(R-FOS, R-GOS, R-MOS). B. thermophilum was detected
during daily treatments with RBL67, at concentrations
ranging from 7.6 and 8.1 log10 CN/mL, but not in the other
treatments and in CR (Table 1). The highest numbers of B.
thermophilum were measured for RBL67 and FOS applied
in combination (R-FOS). N-15 inoculation in absence ofFigure 3 Salmonella cell counts determined in test reactors during tre
effect of prebiotics (FOS, GOS) or RBL67 or combinations of RBL67 with FOS, G
were added to TRs at 108 CN/mL and 5.2 g/day, respectively during a 2 d
inoculated once at 106 cfu/mL and was monitored by plate counts on CH
Cell counts at day 0 correspond to the inoculum added to the reactors.dietary treatments showed no effect on Enterobacteriaceae
numbers, but was associated with a slight but significant in-
crease of the group Lactobacillus/Leuconostoc/Pediococcus
(0.6 log10 CN/mL, period 2) and of Bifidobacterium
(0.6 log10 CN/mL, period 4) compared to CR.
Using 454 pyrosequencing of the entire 16S rRNA gene
pool, a mean value of 6259 ± 3730 quality-filtered reads per
sample was obtained with an average read length of 256 ±
1 bp. All samples revealed the predominance of the 3 phyla,
Firmicutes, Bacteroidetes and Proteobacteria (Additional
file 1: Figure S1). Additionally, Actinobacteria were de-
tected at low levels (<1%; except for R-FOS in period 2
with 1.9%). Firmicutes and Bacteroidetes accounted for
more than 80% of assigned reads in all samples for pe-
riods 2 and 3. However, during period 4, Proteobacteriaatment periods 2–4. Treatment periods 2–4 were used to test the
OS or MOS on Salmonella N-15 colonization. RBL67 and/or prebiotics
ays prevention period and for 5 days after N-15 challenge. N-15 was
ROMAgar™ Salmonella. (─) Salmonella detection limit of 4.1 cfu/mL.
Table 1 16S rRNA gene copy numbers of bacterial groups by qPCR in reactors during periods 2-4














Control n.d. 6.4 ± 0.2 10.3 ± 0.1 9.6 ± 0.1 7.6 ± 0.1 10.0 ± 0.1 10.5 ± 0.1
N-15 n.d. 6.5 ± 0.2 10.3 ± 0.03 9.6 ± 0.1 8.2 ± 0.3* 10.1 ± 0.1 10.5 ± 0.2
RBL67 7.6 ± 0.1 8.3 ± 0.2* 10.2 ± 0.1 10.0 ± 0.1* 7.6 ± 0.2 10.0 ± 0.1 10.6 ± 0.2
FOS n.d. 6.0 ± 0.2* 10.4 ± 0.04 9.9 ± 0.2* 7.4 ± 0.1 10.0 ± 0.03 10.7 ± 0.1
R-FOS 8.1 ± 0.1 8.7 ± 0.2* 10.2 ± 0.2 9.9 ± 0.2 7.4 ± 0.2* 10.0 ± 0.1 10.7 ± 0.1
PERIOD 3
Control n.d. 6.7 ± 0.1 10.0 ± 0.03 10.0 ± 0.1 8.2 ± 0.3 10.0 ± 0.02 10.6 ± 0.1
N-15 n.d. 6.9 ± 0.2 10.1 ± 0.2 9.8 ± 0.1* 8.2 ± 0.2 10.1 ± 0.2 10.6 ± 0.2
RBL67 7.7 ± 0.1 7.7 ± 0.1* 10.1 ± 0.2 10.2 ± 0.1* 8.6 ± 0.2 10.1 ± 0.1 10.6 ± 0.2
GOS n.d. 6.6 ± 0.04 9.9 ± 0.2 9.7 ± 0.2* 8.1 ± 0.2 10.0 ± 0.5 10.5 ± 0.1*
R-GOS 7.7 ± 0.1 8.0 ± 0.1* 10.0 ± 0.2 9.9 ± 0.2 8.3 ± 0.3 10.1 ± 0.3 10.5 ± 0.2
PERIOD 4
Control n.d. 6.4 ± 0.1 10.0 ± 0.2 10.0 ± 0.2 8.0 ± 0.2 9.5 ± 0.02 10.6 ± 0.3
N-15 n.d. 7.0 ± 0.1* 9.9 ± 0.1 9.8 ± 0.1 8.1 ± 0.3 9.8 ± 0.1 10.5 ± 0.1
R-MOS 7.6 ± 0.1 8.1 ± 0.1* 9.8 ± 0.3 9.8 ± 0.2 8.2 ± 0.4 9.5 ± 0.3 10.5 ± 0.4
R-FOS 8.0 ± 0.1 8.4 ± 0.1* 9.8 ± 0.1 9.9 ± 0.2 8.4 ± 0.2* 9.7 ± 0.1 10.5 ± 0.1
R-GOS 7.8 ± 0.1 8.3 ± 0.03* 9.9 ± 0.1 10.0 ± 0.2 8.3 ± 0.2 9.8 ± 0.2 10.6 ± 0.3
*Bacterial populations significantly different (P < 0.05) from CR within a period; Values are given as means ± SD (log10 copy numbers/mL reactor effluent)
calculated from three consecutive days (days 2–4) during N-15 challenge periods.
N-15: Salmonella N-15 without pro- or prebiotic; RBL67: B. thermophilum RBL67 alone; FOS: FOS alone; R-FOS: B. thermophilum RBL67 + FOS; GOS: GOS alone;
R-GOS: B. thermophilum RBL67 + GOS; R-MOS: B. thermophilum RBL67 + MOS.
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decreased to approximately 70% of all reads. The phylum
Proteobacteria displayed a steady increase in all reactors
during the fermentation, including in CR where no treat-
ment was applied. In general, pro- and prebiotic treatments
and N-15 infection did not markedly impact microbiota
composition. At the phylum level, Bacteroidetes increased
and Firmicutes decreased in the N-15 (alone) and RBL67
treatments compared to CR (period 3). On the family level
a consistent increase of Erysipelotrichaceae was observed
with prebiotics, alone (FOS, GOS) or in combination with
RBL67 (R-FOS, R-FOS, R-MOS), compared to CR, with
highest effect for R-FOS (6.4% compared to 0.3% in CR,
period 2 and 4.7% compared to 0.1% in CR, period 4)
(Figure 4). Changes observed at the genus level (Additional
file 2: Figure S2) were consistent with observations at the
family level. The genus Sharpea, a member of the family
Erysipelotrichaceae, was highly abundant in the TRs after
FOS or GOS treatments and the combined treatments of
RBL67 with prebiotics (R-FOS, R-GOS, R-MOS) compared
to CR. The genus increased to 6% (period 2) and 5%
(period 4) of total reads after the R-FOS treatment with
values < 0.1% in CR.Effect of prebiotics, RBL67 and N-15 infection on gut
microbiota metabolism
Metabolite concentrations were measured by HPLC and
mean values of three consecutive days (days 2–4), corre-
sponding to pseudo-steady states of the N-15 challenge
periods, were compared to corresponding data from the
CR (Table 2).
In the CR, the total short chain fatty acid (SCFA) con-
centration was stable from periods 1 to 3 (162 ± 1 mM),
but a slight decrease to 153 ± 1 mM was observed during
period 4, corresponding to a switch of the metabolite
molar ratio (acetate:propionate:butyrate) from 57:29:14
(period 1–3) to 51:34:15 (period 4). The total SCFA con-
centration in the TRs was increased by 29 ± 4% compared
to the CR for treatments with FOS and GOS alone and
combined with RBL67. Acetate (+38 ± 10%) and propion-
ate (+28 ± 4%) levels were most increased with FOS, GOS,
R-FOS and R-GOS, whereas R-FOS also induced a signifi-
cant increase of butyrate (18%, 45% and 7% for period 1, 2
and 4, respectively) compared to the CR. The total SCFA
concentration was also significantly increased in TRs
treated with RBL67 alone (+5 ± 1%, periods 2–3) or with
R-MOS (+11%), although to a lesser extent than for the
Figure 4 Microbial composition in reactors during treatment periods 2–4 measured by 454 pyrosequencing on family level. The microbiota
profile in reactor effluents during treatment periods was analyzed by 454 pyrosequencing of the entire 16S rRNA gene pool in the V5-V6 region. Reactor
effluents were pooled in a ratio 1:1 from two consecutive days of the N-15 challenge period (days 3 and 4) for genomic DNA extraction and subsequent
sequencing on a 454 Life Sciences Genome Sequencer GS FLX instrument. Quality-filtered sequencing reads were assigned using the Ribosomal
Database Project (RDP) Bayesian classifier (v2.1) and applying a confidence threshold of 80%. CR: control reactor; values <1% are summarized
in the group others.
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ate (+12 ± 2%, periods 1–2) and butyrate concentrations
(+16 ± 2%, periods 1–2), while R-MOS mainly stimulated
propionate production (+25%). Infection with N-15 (alone)
had little effect on metabolite productions, except for an
increase in acetate concentration (+11 ± 2%, periods 1 and
4). Branched chain fatty acids (BCFA) were measured
at low amounts (<7 mM) in all reactors. Formate and
lactate were not detected throughout the fermentation
(data not shown).
Discussion
We recently described and validated a novel in vitro con-
tinuous fermentation model (PolyFermS) simulating con-
ditions of the swine proximal colon. The model consists of
parallel reactors inoculated with the same microbiota [33].
In this study, we report the first time application of this
swine PolyFermS model to investigate the effects of a pro-
biotic strain, B. thermophilum RBL67, prebiotics (FOS,
GOS, MOS) and combinations thereof, on S. Typhimurium
N-15 colonization in the presence of a diverse gut
microbiota.
In a first test, RBL67 and N-15 were shown to colonize
the system after one single inoculation. They reached stable
and similar numbers after 1 to 2 days. Our in vitro model
data suggest competitive and adaptive traits of RBL67 and
N-15 in co-culture with the modeled porcine microbiota.
These results are in agreement with previous studies done
with one- and three-stage chemostat models of the child
colon [27,34]. The increasing capacity of N-15 to colonizethe model observed from periods 2 to 4, underlines the
robustness and/or adaptation of Salmonella in simulated
colonic conditions of the swine colon. This suggests that
the PolyFermS model is suitable to mimic a Salmonella car-
rier state of pigs with continuous shedding of Salmonella
[35]. Moreover, an incomplete removal of N-15 during
washing periods of reactors may partly explain the en-
hanced competition of N-15 over time, because viable
cells of Salmonella were detected in the effluents by
plating after careful washing with 10% chlorine for 1 h
and prior to N-15 challenge in periods 3 and 4 (data
not shown). This persistence of Salmonella could be due
to the formation of biofilms in the reactor, which is known
to increase sterilization resistance [36]. This effect may be
avoided in the future by replacing the test reactors with
sterile units before each new treatment period. We also re-
ported an increase of the family Succinivibrionaceae during
the course of the fermentation for the first-stage immobi-
lized cell and all second-stage reactors for the same fer-
mentation test [33]. Salmonella and Succinivibrionaceae
belong to the γ-subclass of the phylum Proteobacteria [37].
Increased numbers of Succinivibrionaceae correlated with
the increased capacity of N-15 to grow in the system, sug-
gesting that this group potentially supported N-15 persist-
ence and growth in periods 3 and 4 after washing. Such
co-occurrence of related bacteria has been previously re-
ported for Salmonella invasion in a mouse infection model
in the presence of high titers of E. coli [38].
Colonization of N-15 in the porcine PolyFermS was
strongly inhibited by the addition of FOS or GOS. This
Table 2 Concentration (mM) and molar ratios (%) of metabolites measured by HPLC during periods 1-4
Acetate Propionate Butyrate total SCFA ratio (acetate:propionate:butyrate)
PERIOD 1
Control 94.6 ± 2.3 45.8 ± 1.3 22.5 ± 0.4 162.9 ± 1.8 58:28:14
N-15 104.2 ± 1.0* 43.6 ± 1.5 22.9 ± 1.1 170.6 ± 3.0* 61:26:13
RBL67 96.8 ± 6.1 43.0 ± 0.3* 25.7 ± 1.0* 165.5 ± 5.4 58:26:16
R-FOS 146.8 ± 5.9* 52.1 ± 3.3* 26.4 ± 0.9* 225.3 ± 1.8* 65:23:12
PERIOD 2
Control 92.4 ± 3.7 48.0 ± 2.0 20.7 ± 0.8 161.0 ± 5.1 57:30:13
N-15 94.0 ± 6.9 45.2 ± 1.1 21.9 ± 1.8 161.1 ± 8.2 58:28:14
RBL67 102.3 ± 2.6* 44.3 ± 1.3* 24.3 ± 1.3* 170.9 ± 5.0* 60:26:14
FOS 126.4 ± 5.2* 58.4 ± 1.1* 21.0 ± 2.4 205.8 ± 6.0* 61:28:10
R-FOS 112.2 ± 1.0* 60.6 ± 0.9* 29.9 ± 1.1* 202.7 ± 1.5* 55:30:15
PERIOD 3
CR 89.5 ± 1.8 46.9 ± 0.1 27.0 ± 1.8 163.4 ± 3.6 55:29:16
SAL 86.1 ± 1.4* 50.0 ± 2.8 22.9 ± 5.2* 159.0 ± 5.2 54:31:14
RBL67 101.3 ± 3.1* 47.3 ± 2.0 22.7 ± 5.9* 171.3 ± 5.9 59:28:13
GOS 122.7 ± 4.8* 61.1 ± 5.5* 21.6 ± 5.0* 205.4 ± 5.0* 60:30:10
R-GOS 117.6 ± 2.0* 60.4 ± 2.7* 27.1 ± 5.9 205.1 ± 6.0* 57:29:13
PERIOD 4
CR 78.7 ± 0.8 51.4 ± 1.0 23.2 ± 0.4 153.3 ± 1.4 51:34:15
SAL 90.1 ± 1.0* 50.9 ± 0.9 22.8 ± 1.7 163.8 ± 1.7* 55:31:14
R-MOS 82.7 ± 3.2* 64.1 ± 1.5* 22.8 ± 2.9 169.3 ± 1.0* 49:38:13
R-FOS 114.6 ± 7.6* 65.0 ± 1.3* 24.7 ± 0.6* 204.3 ± 6.0* 56:32:12
R-GOS 118.5 ± 1.1* 68.2 ± 3.0* 20.1 ± 0.3* 206.8 ± 2.9* 57:33:10
*Means significantly different (P < 0.05) from CR within a metabolite and period using the Kruskal-Wallis pairwise comparison.
Reported are mean values (days 2–4 of N-15 challenge periods) ± SD and ratios are given as percentage of total SCFA (acetate, propionate, butyrate).
N-15: S. Typhimurium N-15 without pro- or prebiotic; RBL67: B. thermophilum RBL67 alone; FOS: FOS alone; R-FOS: B. thermophilum RBL67 + FOS; GOS: GOS alone;
R-GOS: B. thermophilum RBL67 + GOS; R-MOS: B. thermophilum RBL67 +MOS.
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acetate and propionate. A 5 mM undissociated acetic acid
solution was reported to inhibit Salmonella growth [39-41].
In our study, concentrations of undissociated acetic acids
were calculated to be >6 mM (pH= 6.0) for treatments with
FOS and GOS, compared to levels ≤5 mM in the reactor
spiked with N-15 alone. RBL67 combined with FOS or
GOS showed an enhanced inhibition of N-15 compared
to single treatments with pro- or prebiotics. We chose strain
RBL67, because it produces BLIS (thermophilicin B67),
which exhibits an antagonistic effect against Salmonella
and Listeria [24-26]. The production of acetate was de-
creased for R-FOS and R-GOS compared to prebiotics
alone (Table 2). This suggests that BLIS contributed to
N-15 inhibition in combination with organic acids pro-
duced by FOS and GOS. The lower dosage of the pre-
biotic in R-MOS compared to the other combinations
and the stimulation of propionate rather than acetate
production, may explain the less pronounced effect on
N-15 colonization. However, MOS has previously been
shown to block enteropathogen adhesion to the mannose-rich surface glycoproteins of epithelial villi via binding of
its α-D-Mannan to Type 1 fimbriae of enteropathogens
and thus may reduce the risk of infection by this mech-
anism [42].
The antagonistic effect of RBL67 was less pronounced
in this study compared to a previous report [27]. A strong
inhibition of Salmonella and a rapid metabolic rebalancing
of the gut microbiota after antibiotic treatments were ob-
served when RBL67 was added before or after infection in
an in vitro intestinal fermentation model inoculated with
child microbiota [27]. In contrast, Zihler et al. [30] did not
detect an anti-Salmonella effect of RBL67. This may be
explained by different host microbiota, model set-up and
probiotic:pathogen ratios used for all these studies, i.e.
16:1 (this study), 3050:1 [27] and 2:1 [30].
FOS has been reported to stimulate butyrate production
in some studies with piglets [16,43]. In our study, we ob-
served an increased butyrate production with the combin-
ation of FOS and RBL67. Because bifidobacteria do not
produce butyrate [44], we presume that FOS was first de-
graded e.g. by RBL67, followed by cross-feeding reactions
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Megasphaera; [45]). Interestingly, while butyrate has been
linked to a series of health-related properties (reviewed by
Russell et al. [13]), it was also shown to repress invasion
gene expression of Salmonella [14].
The microbiota composition from CR to TR effluents
only changed marginally after RBL67 and prebiotic treat-
ments. In particular, we did not observe a growth stimu-
lation of bifidobacteria or lactobacilli in the FOS and GOS
treatments, as it was previously shown in vitro with hu-
man gut microbiota treated with FOS and inulin [30,46]
or pig microbiota treated with GOS [15,47]. Divergent re-
sults have been reported concerning the effect of FOS and
GOS in vivo. Patterson et al. [12] reported increased
numbers of bifidobacteria and lactobacilli in young pigs
fed with inulin. In contrast, Mountzouris et al. [17] and
Mikkelsen and Jensen [16] did not observe a significant
stimulation of bifidobacteria and lactobacilli in pigs fed
with FOS and transgalactooligosaccharides. These discrep-
ancies may be explained by different prebiotic structures,
dosage and methodology [4,48], complicating a direct com-
parison between the studies. Furthermore, other bacteria of
the gut microbiota, including Salmonella and members of
Roseburia and Bacteroides, can efficiently utilize FOS and
GOS as growth substrates [49-51] and can directly compete
for these nutrients with bifidobacteria and lactobacilli.
Using 454 pyrosequencing, we detected a consistent
increase in the relative abundance of the genus Sharpea
upon addition of prebiotics. This suggests that Sharpea
spp. play a role for prebiotic degradation. They belong to
the family Erysipelotrichaceae within the Clostridium
Cluster XVII. Members of this genus are heterofermenta-
tive and produce lactic acid and CO2 from glucose. They
were first isolated from horse feces and are closely re-
lated to Eggerthia catenaformis [52,53]. Higher net substrate
availability upon prebiotic addition may be responsible for a
higher abundance of Sharpea spp. Erysipelotrichaceae were
also more abundant in pigs with increased feed con-
sumption [54,55], and accounted for a sevenfold higher
proportion in mice fed a high energy diet [56]. Yet, the
exact role of the genus Sharpea remains unclear and fur-
ther insights into prebiotic degradation or its involvement
in possible cross-feeding reactions should be elucidated in
future research.
Conclusion
Our data highlight the suitability of the novel porcine
PolyFermS model to discover ecophysiological changes
resulting from different nutritional treatments on S.
Typhimurium N-15 colonization. We showed that FOS
and GOS distinctively inhibit N-15 colonization in this
model, while the effect was enhanced in presence of B.
thermophilum RBL67. This was likely due to a combined
effect of SCFA and antimicrobial compound productionand competition. We showed that RBL67 stimulates butyr-
ate production in the presence of FOS, beneficially impact-
ing swine gut health. Future research should thus focus on
elucidating the antagonistic mechanisms of RBL67 towards
N-15 in the presence of prebiotics such as FOS and GOS.
Methods
Bacterial strains
B. thermophilum RBL67 (LMG S-23614, Laboratory of
Food Biotechnology, ETH Zurich) was isolated from hu-
man baby feces [26]. S. Typhimurium N-15 was obtained
from a clinical case and was supplied by the National
Center for Enteropathogenic Bacteria and Listeria (NENT;
University of Zurich, Zurich, Switzerland). RBL67 and
N-15 were cultured from a glycerol stock (33%, −80°C) in
serum flasks containing the fermentation medium used to
simulate swine chyme [33], at 37°C for 15 h. The head-
space of the serum flasks was flushed with an N2:CO2
(3:1) gas mixture before autoclaving to generate anaerobic
conditions. Viable cell counts of Salmonella were deter-
mined by plating serial 10-fold dilutions in duplicate on
CHROMAgar™ Salmonella (Becton Dickinson AG, Allschwil,
Switzerland).
Prebiotics
Fibrulose F97 (FOS) (Cosucra Groupe Warcoing S. A.,
Warcoing, Belgium) contains oligofructose (≥97% [wt/wt])
and minor amounts of free fructose, glucose and sucrose
(≤5% [wt/wt]), and has a polymerization degree of 94% ≤20.
Vivinal GOS 90 (GOS), composed of 96.5% GOS, 2%
lactose, 0.7% glucose and 0.8% galactose, was supplied by
Friesland Campina Domo (Amersfoort, Netherlands). Bio-
Mos (MOS) was obtained from Alltech (Sarney, Ireland).
Fermentation set-up
The experimental set-up of the continuous in vitro fer-
mentation model was presented in detail by Tanner et al.
[33]. Briefly, the fermentation model consisted of a two-
stage reactor set-up, with six reactors operated under
conditions of the swine proximal colon (38°C, pH 6.0,
retention time 9 h, anaerobiosis by CO2 headspace flushing)
(Figure 1). The inoculum reactor (IR) containing 30% (v/v)
polysaccharide gel beads immobilizing swine fecal micro-
biota was used to continuously inoculate five subsequent
reactors (one control (CR) and four test reactors (TR1-4))
with 10% effluent. CR and TR1-4 were additionally fed with
90% fresh nutritive medium, designed to simulate swine
chyme [33]. While IR and CR were operated under con-
stant conditions during the entire fermentation period, the
test reactors (TR1-4) were used to test N-15 and RBL67
colonization (period 1) and effects of RBL67 and/or prebi-
otics on N-15 colonization (periods 2–4) (Figure 1). Between
each period, test reactors were disconnected from the
IR, washed with 10% chlorine solution, reconnected and
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minimum 3 days before application of a new treatment [33].
Period 1: RBL67- N-15 colonization
Colonization of S. Typhimurium N-15 and B. thermophilum
RBL67 was tested during period 1 (Figure 1). N-15 was
inoculated in TR1 once to reach a cell concentration of
106 cfu/mL reactor. RBL67 was added once to TR2 and
TR4 for a final gene copy number of 108 CN/mL, while
TR4 was additionally supplied with 5.2 g of FOS/day. Efflu-
ent samples were analyzed after 3, 6, 9, 24, 27, 54, 78 and
96 h for enumeration of Salmonella and B. thermophilum
with plate counts and qPCR, respectively. Measured concen-
trations of N-15 and RBL67 were compared to a theoretical
washout curve, calculated with the formula: ct = c0* e
(−t/RT),
where RT is the mean retention time (9 h), c0 and ct are cell
concentrations of bacteria at time point 0 and t, respectively.
Periods 2–4: N-15 treatment periods
The effects of RBL67, FOS, GOS and combinations of
RBL67 with FOS (R-FOS), GOS (R-GOS) and MOS
(R-MOS) on N-15 colonization were tested during pe-
riods 2–4. For each period one reactor served as con-
trol (CR) and one reactor was infected with N-15 only
(Figure 1). Treatment periods were divided into three
phases: stabilization (stab) was carried out for 3 days (pe-
riods 2 and 4) or 5 days (period 3), prevention (prev) with
pro- and/or prebiotics was done for 2 days, and challenge
with N-15 was tested for 5 days, while addition of RBL67
and/or prebiotics was pursued. During prevention and
challenge periods RBL67 and prebiotics were applied daily
(Figure 1). All test reactors were infected once with N-15
on the first day of the challenge period.
RBL67 and N-15 inoculum was prepared from an over-
night culture, which was centrifuged (6000 × g, 5 min)
and resuspended in fresh fermentation medium. Reactors
were inoculated with a syringe to obtain final concen-
trations of approximately 108 CN/mL for RBL67 and
106 cfu/mL for N-15 corresponding to a probiotic: patho-
gen ratio of approximately 100:1. FOS and GOS were sup-
plied twice daily for a total of 5.2 g/day. This addition level
was selected to correspond to approximately 3% (w/w) of
the daily feed for pigs, considering a 2 kg/d feed intake
and a scale factor of 0.09 for the ratio of the reactor
volume (260 mL) to the pig proximal colon volume in vivo
(approx. 2.9 L [57]). MOS was supplied only once per day
and at 1.5% (w/w, 2.6 g/day), because higher amounts led
to blocking of the flow. Reactor effluent samples were col-
lected daily during the entire fermentation and analyzed
for bacterial composition and activity.
qPCR analyses
Predominant bacterial groups of the swine gut micro-
biota [58] in reactor effluents were enumerated by qPCR.Genomic DNA was extracted using the FastDNA Spin Kit
for soil (MP Biomedicals, Illkirch, France) according to the
manufacturer’s instructions. qPCR targets were: total bac-
teria (total 16S rRNA gene copies), Bacteroides-Prevotella
group, Enterobacteriaceae, Lactobacillus/Pediococcus/
Leuconostoc spp., Clostridium Cluster IV and Bifidobac-
terium spp. (Additional file 3: Table S1). Standard curve
preparation and reaction conditions were carried out as
described by Dostal et al. [59] using a reaction volume of
25 μl and an ABI PRISM 7500-PCR sequence detection
system (Applied Biosystems, Zug, Switzerland). All assays
were carried out using the 2 × SYBR Green PCR Master
Mix (Applied Biosystems).
B. thermophilum enumeration was performed using
primers bthermRTF and bthermRTR and the Taqman
probe bthermTqm (Additional file 3: Table S1) [60]. The
RT-QP2X-03WOULR Mastermix (Eurogentec s.a., Seraing,
Belgium) was used and standard curve preparation and re-
action conditions were carried out as described previously
[59,60].
Pyrosequencing
Effluent samples of CR and TRs from periods 2–4 were
analyzed using 454 pyrosequencing on the V5-V6 region
of the entire 16S rRNA gene pool. Reactor effluents from
two consecutive days during the N-15 challenge (day 3 and
4) were pooled in a ratio 1:1, prior to DNA extraction
using the FastDNA SPIN Kit for soil (MP Biomedicals).
Genomic DNA extracts were sequenced by DNAVision SA
(Charleroi, Belgium) on a 454 Life Sciences Genome Sequen-
cer GS FLX instrument (Roche AG, Basel, Switzerland), and
subsequent taxonomic assignment of the 16S rRNA gene
reads was done as described previously [61]. Quality-filtered
sequencing reads were assigned using the Ribosomal
Database Project (RDP) Bayesian classifier (v 2.1) [62]
and applying a confidence threshold of 80%. The entire
454 pyrosequencing dataset has been deposited to the
National Center for Biotechnology (NCBI) Sequence Read
Archive under accession number SRP044728.
Metabolite analysis
Reactor effluents were analyzed for SCFAs (acetate, pro-
pionate and butyrate), BCFAs (valerate, iso-valerate and
iso-butyrate), formate and lactate by HPLC (Thermo Fisher
Scientific Inc. Accela, Wohlen, Switzerland) [33]. Effluent
samples were centrifuged (14 000 × g, 10 min, 4°C); the
resulting supernatant was diluted 1:10 with ultrapure water
and directly filtered through a 0.45 μm nylon filter (Info-
chroma AG, Zug, Switzerland). The analysis was carried
out using an Aminex HPX-87H column (Bio-Rad Labora-
tories AG, Reinach, Switzerland) and 10 mM H2SO4 as
eluent. Mean metabolite concentrations (mM) were esti-
mated from duplicate analyses. Total SCFA contents cor-
respond to the sum of acetate, propionate and butyrate.
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All statistical analyses were performed using JMP 10.0
(SAS Institute Inc., Cary, NC). Prior to statistical analysis
qPCR data were log10 transformed. HPLC and qPCR
data are expressed as means ± SD from three consecu-
tive days (days 2–4) during N-15 challenge periods. Me-
tabolite and qPCR data from each treatment reactor were
compared pairwise to the control reactor within the same
period using the non-parametric Kruskal-Wallis Test.
P-values <0.05 were considered significant.
Additional files
Additional file 1: Figure S1. Microbial composition in reactors during
treatment periods 2–4 measured by 454 pyrosequencing on phylum
level. Microbial composition in reactor effluents was analyzed by 454
pyrosequencing of the entire 16S rRNA gene pool in the V5-V6
region. Reactor effluents were pooled in a ratio 1:1 from two consecutive
days of the N-15 challenge period (days 3 and 4) for genomic DNA
extraction and subsequent sequencing on a 454 Life Sciences Genome
Sequencer GS FLX instrument. Quality-filtered sequencing reads were
assigned using the Ribosomal Database Project (RDP) Bayesian classifier
(v2.1) and applying a confidence threshold of 80%. CR: control reactor;
values <1% are summarized in the group others.
Additional file 2: Figure S2. Microbial composition in reactors during
treatment periods 2–4 measured by 454 pyrosequencing on genus level.
Microbial composition in reactor effluents was analyzed by 454
pyrosequencing of the entire 16S rRNA gene pool in the V5-V6
region. Reactor effluents were pooled in a ratio 1:1 from two consecutive
days of the N-15 challenge period (days 3 and 4) for genomic DNA ex-
traction and subsequent sequencing on a 454 Life Sciences Genome Se-
quencer GS FLX instrument. Quality-filtered sequencing reads were
assigned using the Ribosomal Database Project (RDP) Bayesian classifier
(v2.1) and applying a confidence threshold of 80%. CR: control reactor;
values <1% are summarized in the group others.
Additional file 3: Table S1. Primers and probes used for detection of
bacterial target groups with qPCR.
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